These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22586270)

  • 1. Identification of estrogen receptor β as a SUMO-1 target reveals a novel phosphorylated sumoylation motif and regulation by glycogen synthase kinase 3β.
    Picard N; Caron V; Bilodeau S; Sanchez M; Mascle X; Aubry M; Tremblay A
    Mol Cell Biol; 2012 Jul; 32(14):2709-21. PubMed ID: 22586270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMO-1 controls the protein stability and the biological function of phosducin.
    Klenk C; Humrich J; Quitterer U; Lohse MJ
    J Biol Chem; 2006 Mar; 281(13):8357-64. PubMed ID: 16421094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination.
    Luo HB; Xia YY; Shu XJ; Liu ZC; Feng Y; Liu XH; Yu G; Yin G; Xiong YS; Zeng K; Jiang J; Ye K; Wang XC; Wang JZ
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16586-91. PubMed ID: 25378699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the regulation of heat shock transcription factor 1 SUMO-1 modification.
    Hilgarth RS; Hong Y; Park-Sarge OK; Sarge KD
    Biochem Biophys Res Commun; 2003 Mar; 303(1):196-200. PubMed ID: 12646186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
    Parker JL; Ulrich HD
    Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small ubiquitin-like modifier (SUMO) modification of zinc finger protein 131 potentiates its negative effect on estrogen signaling.
    Oh Y; Chung KC
    J Biol Chem; 2012 May; 287(21):17517-17529. PubMed ID: 22467880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phosphotyrosine switch determines the antitumor activity of ERβ.
    Yuan B; Cheng L; Chiang HC; Xu X; Han Y; Su H; Wang L; Zhang B; Lin J; Li X; Xie X; Wang T; Tekmal RR; Curiel TJ; Yuan ZM; Elledge R; Hu Y; Ye Q; Li R
    J Clin Invest; 2014 Aug; 124(8):3378-90. PubMed ID: 24960160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca
    Silveirinha VC; Lin H; Tanifuji S; Mochida S; Cottrell GS; Cimarosti H; Stephens GJ
    Cell Calcium; 2021 Jan; 93():102326. PubMed ID: 33360835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An extended consensus motif enhances the specificity of substrate modification by SUMO.
    Yang SH; Galanis A; Witty J; Sharrocks AD
    EMBO J; 2006 Nov; 25(21):5083-93. PubMed ID: 17036045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective SUMO modification of cAMP-specific phosphodiesterase-4D5 (PDE4D5) regulates the functional consequences of phosphorylation by PKA and ERK.
    Li X; Vadrevu S; Dunlop A; Day J; Advant N; Troeger J; Klussmann E; Jaffrey E; Hay RT; Adams DR; Houslay MD; Baillie GS
    Biochem J; 2010 Apr; 428(1):55-65. PubMed ID: 20196770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypic SUMOylation of Nor1/NR4A3 regulates neural cell viability and redox sensitivity.
    Gagnon J; Caron V; Gyenizse L; Tremblay A
    FASEB J; 2021 Sep; 35(9):e21827. PubMed ID: 34383980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif.
    Matic I; Schimmel J; Hendriks IA; van Santen MA; van de Rijke F; van Dam H; Gnad F; Mann M; Vertegaal AC
    Mol Cell; 2010 Aug; 39(4):641-52. PubMed ID: 20797634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Casein kinase-2-mediated phosphorylation increases the SUMO-dependent activity of the cytomegalovirus transactivator IE2.
    Tripathi V; Chatterjee KS; Das R
    J Biol Chem; 2019 Oct; 294(40):14546-14561. PubMed ID: 31371453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMOylation regulates the intracellular fate of ZO-2.
    Wetzel F; Mittag S; Cano-Cortina M; Wagner T; Krämer OH; Niedenthal R; Gonzalez-Mariscal L; Huber O
    Cell Mol Life Sci; 2017 Jan; 74(2):373-392. PubMed ID: 27604867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein Kinase A Opposes the Phosphorylation-dependent Recruitment of Glycogen Synthase Kinase 3β to A-kinase Anchoring Protein 220.
    Whiting JL; Nygren PJ; Tunquist BJ; Langeberg LK; Seternes OM; Scott JD
    J Biol Chem; 2015 Aug; 290(32):19445-57. PubMed ID: 26088133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CK2-RNF4 interplay coordinates non-canonical SUMOylation and degradation of nuclear receptor FXR.
    Bilodeau S; Caron V; Gagnon J; Kuftedjian A; Tremblay A
    J Mol Cell Biol; 2017 Jun; 9(3):195-208. PubMed ID: 28201649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3.
    Subramanian L; Benson MD; Iñiguez-Lluhí JA
    J Biol Chem; 2003 Mar; 278(11):9134-41. PubMed ID: 12511558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells.
    Woo CH; Shishido T; McClain C; Lim JH; Li JD; Yang J; Yan C; Abe J
    Circ Res; 2008 Mar; 102(5):538-45. PubMed ID: 18218985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted identification of SUMOylation sites in human proteins using affinity enrichment and paralog-specific reporter ions.
    Lamoliatte F; Bonneil E; Durette C; Caron-Lizotte O; Wildemann D; Zerweck J; Wenshuk H; Thibault P
    Mol Cell Proteomics; 2013 Sep; 12(9):2536-50. PubMed ID: 23750026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor.
    Tirard M; Almeida OF; Hutzler P; Melchior F; Michaelidis TM
    Mol Cell Endocrinol; 2007 Mar; 268(1-2):20-9. PubMed ID: 17314004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.